Opioid agonist therapy uptake among people who inject drugs: the findings of two consecutive bio-behavioral surveillance surveys in Iran.
Mehran NakhaeizadehZahra AbdolahiniaHamid SharifiAli MirzazadehAli Akbar HaghdoostMostafa ShokoohiStefan David BaralMohammad KaramouzianArmita ShahesmaeiliPublished in: Harm reduction journal (2020)
Although OAT uptake among PWID in Iran is above the 40% threshold defined by the World Health Organization, there remain significant disparities across urban settings in Iran. Importantly, the OAT services appear to be serving high-risk PWID including those living with HIV and those with a history of incarceration. Evaluating service integration including mental health, HIV and hepatitis C virus care, and other harm reduction services may support the optimization of health outcomes associated with OAT across Iran.